Skip to main content
. 2016 Nov 24;37(1):41–47. doi: 10.3892/or.2016.5274

Figure 3.

Figure 3.

(A) Nuclei after FISH with an IGH/BCL2 probe in primitive STUMP. (B) Nuclei after FISH with an IGH/BCL2 probe in relapsed sarcoma. (C) Distribution of BCL2 and IGH signals in primitive STUMP. (D) Distribution of BCL2 and IGH signals in relapsed sarcoma. (E) Distribution of BCL2 and CEP18 probe signals in undifferentiated sarcoma (left) and nuclei with polysomy of chromosome 18 (right). (F) Distribution of BCL2 and CEP18 probe signals in case 2. (G) Distribution of BCL2 and CEP18 probe signals in case 3. (H) Distribution of UroVysion probe signals on primitive STUMP. STUMP, smooth muscle tumors of uncertain malignant potential.